|Day Low/High||3.13 / 3.46|
|52 Wk Low/High||1.74 / 6.68|
Investors in Geron Corp. saw new options become available this week, for the July 20th expiration.
Jim Cramer takes a closer look at Box, Applied Materials, Goodyear, Geron, Cognex, Jacobs Engineering, Editas Medicine.
Expectations about earnings are totally out of whack, says Jim Cramer. Will Apple's earnings break the spell?
Jim Cramer highlights Spotify, Alkermes, Sorrento Therapeutics, Thermo Fisher Scientific, Kohlberg Kravis Roberts, and more.
Washington receded and earnings came to the fore, but we're still seeing insane values and some surprises, says Jim Cramer.
Levi & Korsinsky announces it has commenced an investigation of Geron Corporation ("Geron" or "the Company") (NASDAQGS: GERN) concerning possible violations of federal securities laws.
Girard Gibbs LLP is investigating claims on behalf of investors of Geron Corporation (NASDAQ:GERN) involving possible securities law violations.
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Geron Corporation (NASDAQ: GERN) resulting from allegations that Geron may have...
Investors in Geron Corp. saw new options begin trading this week, for the May 18th expiration.
Conference Call Scheduled for 8:30 a.m. ET on Monday, March 19
Small-cap stocks have finally jumped back to life on prospects for a strong U.S. economy this year. What trade war?
Management to be joined by external guest speaker to review imetelstat data from IMerge to be presented at the 59th American Society of Hematology Annual Meeting and Exposition
Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes to be Presented
The FDA granted fast track designation to imetelstat as a potential treatment for adults with with transfusion-dependent anemia.
Expanded Part 1 of IMerge is Open for Patient Enrollment
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.